Elon Musk Says He Doesn't Want to Buy TikTok's US Business After All
Elon Musk said he isn't interested in buying TikTok, the popular social video app the US has tried to ban over national security concerns with its Chinese owner Bytedance Ltd.
He made the comments — his first on the topic of him buying TikTok — at a conference in Germany hosted by Mathias Doepfner, the billionaire chief executive of German media conglomerate AxelSpringer, last month.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
What the market may have to say about Trump's unilateral tariffs
President Trump stated that he plans to install unilateral tariff rates for trading partners in two weeks. This comes after the administration touted a trade deal with China on Wednesday, including a 55% tariff on Chinese imports, that the two nations' leaders still have to agree upon. Charles Schwab senior investment strategist Kevin Gordon sits down with Brad Smith about how markets (^DJI, ^IXIC, ^GSPC) have been reacting in this tariff saga and how these themes have fed into the economy and GDP figures. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
25 minutes ago
- Yahoo
Chinese automotive price war could affect European markets: Indicata
The ongoing price war in China's electric vehicle (EV) market could impact European new and used car markets, according to Indicata, a unit of Autorola Group. As Chinese automakers cut prices by up to 34% and EV discounts average 17%, ripple effects could affect car values across Europe and the UK. The Chinese market is experiencing intense competition with more than 100 EV brands and is projected to exceed 33 million vehicles by 2025. Indicata global business unit director Andy Shields said: 'Chinese OEMs are facing massive oversupply and intense competition in their domestic market.' BYD recently announced price cuts across 25 models due to excess inventory, compressing vehicle margins industry-wide. Indicata's analysis also highlights significant barriers for Chinese manufacturers in other markets. The US market remains largely inaccessible due to high tariffs. Other global markets outside Europe could absorb internal combustion engine (ICE) and plug-in hybrid electric vehicles (PHEV) but lack the infrastructure for battery-electric vehicle (BEV) adoption, the technology vendor explained. Chinese manufacturers are shifting focus from BEVs to ICE and hybrid vehicles. This strategic shift addresses tariff considerations and slower-than-expected BEV demand. Indicata projects increasing pressure on the EU, UK, Brazil, Mexico, and Australia to absorb Chinese vehicles, including PHEVs. 'Whilst there are tariffs in place for BEVs in the EU, it's still possible for Chinese manufacturers to sell BEVs in Europe more profitably than in their home market,' Shields added. 'The UK market is particularly exposed, as there are currently no additional tariffs on Chinese BEVs. Indicata said that the competitive landscape is unsustainable, with most manufacturers needing one million vehicle production annually for profitability. Only a few brands, including BYD, Li Auto, and Seres, report consistent margins while others such as Nio face cash burn impacting profits. Industry consolidation appears unavoidable as smaller firms confront acquisition or risk exiting the market, Indicata said. Recognising the sector's instability, the Chinese Government is signalling broader shifts ahead for the global automotive landscape. Chinese EV manufacturers aim for 50% of sales from international markets, with exports already at 33% of China's total EV production in early 2025. However, this strategy risks geopolitical tensions, evolving tariffs, and regulatory barriers. European consumers may benefit from lower-priced, advanced vehicles in the short term, but long-term implications for used car markets could be significant, as competitively priced Chinese vehicles might pressure used vehicle valuations. Automakers such as Volkswagen and Honda struggle to compete with Chinese EVs, while the price war in China further challenges Western manufacturers. These OEMs may focus more on their home markets in Europe, leading to increased competition and price wars to avoid CO₂ penalties, impacting sales of both new and used vehicles during 2025. "Chinese automotive price war could affect European markets: Indicata" was originally created and published by Motor Finance Online, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
27 minutes ago
- Yahoo
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
BioNTech will acquire all shares of CureVac after the two sides reached an agreement in a deal valued around $1.25 billion. Each share of CureVac, a clinical-stage biotech company, will be exchanged for about $5.46 in BioNTech American depositary shares. Upon the deal's closing, CureVac shareholders are expected to own between 4% and 6% of the German developer of RNA vaccines and immunotherapies. ICE Raids Have Sent Latino Shoppers Into Hiding and Big Brands Are Hurting The Secret to Retaining the Best Employees: Ask Them These Four Questions Here's How Much Money the U.S. Is Earning From Tariffs, in Charts How Home Depot Became Ground Zero in Trump's Deportation Push Supply Chains Become New Battleground in the Global Trade War BioNTech Chief Executive Ugur Sahin said the plan is to bring complementary capabilities between the two companies together to develop transformative cancer treatments. CureVac's operating subsidiary will become a wholly owned subsidiary of BioNTech following the close of the transaction. As part of this plan, BioNTech will integrate CureVac's research and manufacturing site in Tübingen, Germany. The deal was unanimously approved by both companies' management and supervisory boards. It is expected to close in 2025. Shares of CureVac surged 29% to $5.25 in premarket trading. Write to Denny Jacob at Pulls Outlook as Sales Fall Bojangles Is Exploring a Sale While the Fried-Chicken Market Is Hot Why Bosses Should Give Feedback in the Morning The Audacious Reboot of America's Nuclear Energy Program Muted May Inflation Defies Tariff Fears Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
